Parents' willingness to vaccinate themselves and their children with the booster vaccine against SARS-CoV-2: A cross-sectional study in Puyang city, China

被引:2
|
作者
Zhou, Yiguo [1 ,2 ]
Li, Guo-Xing [1 ]
Zhao, Tian-Shuo [1 ]
Du, Juan [1 ]
Zhang, Wan-Xue [1 ]
Xie, Ming-Zhu [1 ]
Chen, Lin-Yi [1 ]
Zeng, Jing [1 ,3 ,4 ]
Wang, Chao [1 ]
Liu, Bei [1 ]
Liu, Ya-Qiong [1 ,3 ,4 ]
Cui, Fuqiang [1 ,2 ,3 ,4 ]
Lu, Qing-Bin [1 ,2 ,3 ,4 ]
机构
[1] Peking Univ, Vaccine Res Ctr, Sch Publ Hlth, Dept Laboratorial Sci & Technol, 38 Xue Yuan Rd, Beijing 100191, Peoples R China
[2] Peking Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Beijing, Peoples R China
[3] Peking Univ, Global Ctr Infect Dis & Policy Res, Beijing, Peoples R China
[4] Peking Univ, Global Hlth & Infect Dis Grp, Beijing, Peoples R China
基金
北京市自然科学基金;
关键词
booster shot; COVID-19; SARS-CoV-2; vaccine hesitancy; willingness; COVID-19; VACCINE; INFECTION; BNT162B2; WORKERS;
D O I
10.1002/jmv.28256
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
We aimed to investigate the hesitancy and willingness of parents to vaccinate themselves and their children with a booster dose against severe acute respiratory syndrome coronavirus 2 and related factors. We conducted a cross-sectional study in Puyang city, China. The information was collected, including demographic characteristics, willingness to receive a booster dose of coronavirus disease 2019 (COVID-19) vaccine, and attitudes and concerns toward COVID-19 and vaccines. Vaccine hesitancy was assessed in individuals completing the first two doses and booster eligible, while vaccine willingness was assessed in those completing the first two doses and not yet booster eligible. Among the participants completing two primary doses while not meeting the booster criteria, 95.4% (1465/1536) and 95.0% (1385/1458) had a willingness to a booster dose of COVID-19 vaccine for themselves and their children, respectively. Among the participants who met the booster criteria, 40.3% had vaccine hesitancy. Vaccine hesitancy and unwillingness tended to occur in people who were younger, less educated, less healthy, and with unsureness of vaccines' efficacy and adverse events (AE). The younger age of children, children in poorer health, and concern about the efficacy and AE of vaccines contributed to the participants' unwillingness to vaccinate their children. We observed a high willingness to the booster dose of COVID-19 vaccine both for the parents and their children, regardless of the eligibility to a booster dose. However, 40% of people had delayed vaccination behaviors. The promotion of scientific knowledge of vaccines' effectiveness and safety is needed, especially for people in poor health and parents with young children. Timely disclosure of AE caused by COVID-19 vaccines and proper aiding offered to people encountering AE are suggested.
引用
收藏
页数:10
相关论文
共 50 条
  • [41] Caregiver Willingness to Vaccinate Children with Pneumococcal Vaccines and to Pay in a Low-Resource Setting in China: A Cross-Sectional Study
    Li, Linqiao
    Ma, Yuan
    Li, Wei
    Tang, Guorong
    Jiang, Yan
    Li, Huangcui
    Jiang, Shuxiang
    Zhou, Yun
    Yang, Yuan
    Zhang, Ting
    Yang, Weizhong
    Ma, Libing
    Feng, Luzhao
    VACCINES, 2022, 10 (11)
  • [42] Explore the reasons for SARS-CoV-2 vaccine hesitancy among healthcare workers: a cross-sectional study
    Bereda, Gudisa
    ANNALS OF MEDICINE AND SURGERY, 2023, 85 (06): : 2443 - 2450
  • [43] Immunogenicity and safety of an inactivated SARS-CoV-2 vaccine in people living with HIV: A cross-sectional study
    Cai, Shaohang
    Liao, Guichan
    Yu, Tao
    Gao, Qiqing
    Zou, Lirong
    Zhang, Huan
    Xu, Xuwen
    Chen, Juanjuan
    Lu, Aili
    Wu, Yingsong
    Li, Baisheng
    Peng, Jie
    JOURNAL OF MEDICAL VIROLOGY, 2022, 94 (09) : 4224 - 4233
  • [44] SARS-CoV-2 Vaccine Uptake among Patients with Chronic Liver Disease: A Cross-Sectional Analysis in Hebei Province, China
    Liu, Yongmei
    Yuan, Wenfang
    Zhan, Haoting
    Kang, Haiyan
    Li, Xiaomeng
    Chen, Yongliang
    Li, Haolong
    Sun, Xingli
    Cheng, Linlin
    Zheng, Haojie
    Wang, Wei
    Guo, Xinru
    Li, Yongzhe
    Dai, Erhei
    VACCINES, 2023, 11 (08)
  • [45] Predictors of SARS-CoV-2 Vaccine Uptake among Health Professionals: A Cross-Sectional Study in Ghana
    Mohammed, Abdul-Samed
    Asumah, Mubarick Nungbaso
    Padhi, Bijaya Kumar
    Sinha, Abhinav
    Mohammed, Issah
    Jamil, Safayet
    Boasiako, Osborn Antwi
    Leman, Nladobi
    Kabir, Russell
    VACCINES, 2023, 11 (01)
  • [46] The coverage of SARS-CoV-2 vaccination and the willingness to receive the SARS-CoV-2 variant vaccine among employees in China
    Xi-Ru Zhang
    Zhi-Ju Li
    Qi Fu
    Jin-Dong Wang
    Qing-Mei Huang
    Wei-Qi Song
    Xiao-Yu Xu
    Zhi-Hao Li
    Chen Mao
    BMC Public Health, 23 (1)
  • [47] Willingness of Older Adults with Chronic Diseases to Receive a Booster Dose of Inactivated Coronavirus Disease 2019 Vaccine: A Cross-Sectional Study in Taizhou, China
    Lin, Xiao-Qing
    Li, A-Li
    Zhang, Mei-Xian
    Lv, Li
    Chen, Yan
    Chen, He-Dan
    Tung, Tao-Hsin
    Zhu, Jian-Sheng
    VACCINES, 2022, 10 (10)
  • [48] Prediction models for neutralization activity against emerging SARS-CoV-2 variants: A cross-sectional study
    Goto, Atsushi
    Miyakawa, Kei
    Nakayama, Izumi
    Yagome, Susumu
    Xu, Juan
    Kaneko, Makoto
    Ohtake, Norihisa
    Kato, Hideaki
    Ryo, Akihide
    FRONTIERS IN MICROBIOLOGY, 2023, 14
  • [49] The Presence of Lung Cancer Affects SARS-CoV-2 Vaccine Uptake and Attitude in Chinese Patients: A Clinical Cross-Sectional Investigation
    Chen, Chen
    Pan, Ruili
    Dai, Liyuan
    Chen, Minjiang
    Zhao, Jing
    Zhong, Wei
    Wang, Mengzhao
    Liu, Hongsheng
    Xu, Yan
    Han, Xiaohong
    CANCER INVESTIGATION, 2023, : 601 - 616
  • [50] Management of SARS-CoV-2 Omicron Variant Community Screenings in Shanghai, China: A Cross-Sectional Study
    Chen, Keyu
    Xu, Bin
    Tang, Yifan
    Cao, Juan
    Wang, Rong
    Tian, Yali
    Gao, Chunhong
    Chu, Ming
    RISK MANAGEMENT AND HEALTHCARE POLICY, 2023, 16 : 111 - 120